Wikrom Karnsakul

1.4k total citations
62 papers, 472 citations indexed

About

Wikrom Karnsakul is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Wikrom Karnsakul has authored 62 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hepatology, 32 papers in Epidemiology and 21 papers in Surgery. Recurrent topics in Wikrom Karnsakul's work include Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (19 papers) and Hepatitis B Virus Studies (17 papers). Wikrom Karnsakul is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (19 papers) and Hepatitis B Virus Studies (17 papers). Wikrom Karnsakul collaborates with scholars based in United States, Thailand and Italy. Wikrom Karnsakul's co-authors include Kathleen B. Schwarz, Peter J. Mogayzel, John C. Magee, Kiyoko Oshima, Thammasin Ingviya, Supawadee Likitmaskul, Saroj Nimkarn, Jean P. Molleston, Jeerunda Santiprabhob and Daniel H. Leung and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of Hepatology.

In The Last Decade

Wikrom Karnsakul

58 papers receiving 466 citations

Peers

Wikrom Karnsakul

HEPAT

EPIDE

SURGE

PRM

GENET

Girish Subbarao United States

Nidah S. Khakoo United States

Naresh Shanmugam India

Mircea Mănuc Romania

Funda Özgenç Türkiye

Hyoung Su Kim South Korea

Matthew T. Kitson Australia

Rima Fawaz United States

Rajani Sharma United States

Magd A. Kotb Egypt

Girish Subbarao United States

Wikrom Karnsakul

88 ×0.4

HEPAT

81 ×0.5

EPIDE

148 ×1.1

SURGE

73 ×0.6

PRM

20 ×0.3

GENET

Citations per year, relative to Wikrom Karnsakul Wikrom Karnsakul (= 1×) peers Girish Subbarao

Countries citing papers authored by Wikrom Karnsakul

Since Specialization

Citations

This map shows the geographic impact of Wikrom Karnsakul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wikrom Karnsakul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wikrom Karnsakul more than expected).

Fields of papers citing papers by Wikrom Karnsakul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wikrom Karnsakul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wikrom Karnsakul. The network helps show where Wikrom Karnsakul may publish in the future.

Co-authorship network of co-authors of Wikrom Karnsakul

This figure shows the co-authorship network connecting the top 25 collaborators of Wikrom Karnsakul. A scholar is included among the top collaborators of Wikrom Karnsakul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wikrom Karnsakul. Wikrom Karnsakul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Erin, et al.. (2025). Navigating Epstein–Barr Virus (EBV) and Post-Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Liver Transplantation: Current Knowledge and Strategies for Treatment and Surveillance. Viruses. 17(2). 254–254. 1 indexed citations

Hartley, Christopher, et al.. (2025). Varicella and Zoster Vaccination Strategies in Immunosuppressed Pediatric Transplant Recipients. Vaccines. 13(5). 534–534.

Quirós‐Tejeira, Rubén E., et al.. (2025). Pediatric Non-Alcoholic Fatty Liver Disease (NAFLD): Trends, Mortality, and Socioeconomic Disparities in the U.S., 1998–2020. Children. 12(1). 71–71. 1 indexed citations

González‐Peralta, Regino P., Jessica Wen, Winita Hardikar, et al.. (2025). Long-term efficacy and safety of sofosbuvir-based direct-acting antiviral regimens in paediatric patients with hepatitis C virus infection: an international registry study. The Lancet Child & Adolescent Health. 9(4). 248–254. 1 indexed citations

Presnell, Brett, et al.. (2024). A Composite Score for Predicting Vertical Transmission of Hepatitis C: A Multicenter Study. Pathogens. 13(1). 45–45. 2 indexed citations

Hartley, Christopher, et al.. (2024). Exploring odevixibat’s efficacy in alagille syndrome: insights from recent clinical trials and IBAT inhibitor experiences. Expert Opinion on Pharmacotherapy. 25(12). 1647–1655. 2 indexed citations

Hartley, Christopher, et al.. (2024). Hepatitis E Vaccines Updates. Vaccines. 12(7). 722–722. 2 indexed citations

Hartley, Christopher, et al.. (2024). Direct-Acting Antiviral Agents in Prevention of Maternal–Fetal Transmission of Hepatitis C Virus in Pregnancy. Pathogens. 13(6). 508–508. 1 indexed citations

Egerman, Robert, et al.. (2024). Hepatitis C Prevalence and Birth Outcomes among Pregnant Women in the United States: A 2010–2020 Population Study. Pathogens. 13(4). 321–321.

10.

Hartley, Christopher, et al.. (2024). Live-Attenuated Vaccines in Pediatric Solid Organ Transplant. Vaccines. 12(4). 376–376. 1 indexed citations

11.

Ingviya, Thammasin, Paul K. Sue, Annette M. Jackson, et al.. (2023). Risk factors associated with Hepatitis E virus infection in kidney transplant recipients in a single tertiary Center in the United States. Transplant Immunology. 78. 101809–101809. 3 indexed citations

12.

Karnsakul, Wikrom, et al.. (2023). Hepatitis A hospitalisations in the United States and risk factors for inpatient mortality: A nationwide population study, 1998–2020. Journal of Viral Hepatitis. 31(2). 88–95. 1 indexed citations

13.

Towbin, Alexander J., Wen Ye, Suiyuan Huang, et al.. (2023). Prospective study of quantitative liver MRI in cystic fibrosis: feasibility and comparison to PUSH cohort ultrasound. Pediatric Radiology. 53(11). 2210–2220. 3 indexed citations

14.

Oshima, Kiyoko, et al.. (2023). Applicability of International Autoimmune Hepatitis Group (IAIHG) Scoring System for Autoimmune Hepatitis in Pediatrics. Biology. 12(3). 479–479. 4 indexed citations

15.

Striley, Catherine W., et al.. (2022). Hepatitis D‐associated hospitalizations in the United States: 2010–2018. Journal of Viral Hepatitis. 29(3). 218–226. 8 indexed citations

16.

Lowry, Sarah, et al.. (2022). Vanishing bile duct syndrome after drug-induced liver injury. Clinics and Research in Hepatology and Gastroenterology. 46(9). 102015–102015. 8 indexed citations

17.

Ingviya, Thammasin, Eyasu H. Teshale, Saleem Kamili, et al.. (2020). Hepatitis E‐Associated Hospitalizations in the United States: 2010–2015 and 2015–2017. Journal of Viral Hepatitis. 28(4). 672–681. 10 indexed citations

18.

Karnsakul, Wikrom, et al.. (2020). A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease. Journal of Cystic Fibrosis. 19(4). 546–552. 17 indexed citations

19.

Karnsakul, Wikrom, et al.. (2012). Isolated positive anti-gliadin immunoglobin-A antibody in children with gastrointestinal symptoms. The Turkish Journal of Gastroenterology. 23(5). 485–489. 4 indexed citations

20.

Karnsakul, Wikrom, et al.. (2009). Managing pediatric hepatitis C: current and emerging treatment options. SHILAP Revista de lepidopterología. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact